Introduction
International Council for Harmonisation (ICH) E14 guidance agreed to use a model-based study of concentration-QT data as a primary analysis in the proarrhythmic risk assessment
Modelling guidelines: pre-specified LME model presented in “Scientific white paper on concentration-QTc modelling” by Ch.
Garnett et al. ( J. Pharmacokinet. Phar. 2017)
- Check the model assumption via exploratory plots
- Develop the relationship between a drug concentration and the change from baseline of the heart rate corrected QT interval
corrected by placebo (ΔΔQTc) - Compute the mean ΔΔQTc at concentration of interest and 90% double sided confidence interval
- Assess if the QTc prolongation exceeds the 10ms regulatory threshold
Presented at ACoP 11 Virtual Conference, Nov. 9-13, 2020
By Monika Twarogowska, Géraldine Ayral, Jonathan Chauvin, Pauline Traynard